AmyLaurenCummingsMD

Physician

Dr. Cummings is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
3445 Pacific Coast Hwy
Ste 300
Torrance, CA 90505
Phone+1 310-325-8252

Fax+1 310-325-8252

Amy Cummings, MD PhD, is an oncologist based in Santa Monica, CA. She completed her medical education at the Keck School of Medicine, University of Southern California, and later pursued a residency in Internal Medicine at UCLA David Geffen School of Medicine/UCLA Medical Center from 2013 to 2016. Dr. Cummings has contributed to major publications in the field of Oncology, with a key focus on lung cancer, immune checkpoint inhibitors, and issues in clinical trial enrollment. Her work is well-recognized and has been cited multiple times by other professionals in the field.

UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 2013 - 2016
Keck School of Medicine of the University of Southern CaliforniaClass of 2013

PubMed

14 citations
Targeted Therapy for Non-Small Cell Lung Cancer.
Zorawar S. Noor, Amy L. Cummings, McKenna M. Johnson, Marshall L. Spiegel, Jonathan W. Goldman
Seminars in Respiratory and Critical Care Medicine. 2020-05-25
21 citations
Mutational landscape influences immunotherapy outcomes among patients with non-small-cell lung cancer with human leukocyte antigen supertype B44
Amy L. Cummings, Jaklin Gukasyan, Henry Lu, Tristan Grogan, Gemalene Sunga
Nature Cancer. 2020-11-16
11 citations
Low Concordance of Patient-Reported Outcomes With Clinical and Clinical Trial Documentation
Charlene M. Fares, Timothy Williamson, Matthew K. Theisen, Amy L. Cummings, Krikor Bornazyan
JCO Clinical Cancer Informatics. 2018-11-16

Lectures

Electrostatic human leukocyte antigen-neoantigen interactions and durable benefit in non-small cell lung cancer patients treated with immunotherapy.
2019 ASCO Annual Meeting - 6/1/2019

Amy Cummings, MD, PhD, and Romel Somwar, PhD, Honored as Recipients of the Hamoui Foundation/LUNGevity Clinical Research AwardNovember 20th, 2024
Doctors Are Begging You to Pay Attention to This Early Lung Cancer SignNovember 15th, 2024
What You Need to Know About Lung CancerNovember 4th, 2024
Join now to see all